Form 4: Omada Health President Wei-Li Shao Reports Significant RSU Grant

Omada Health, Inc. President Wei-Li Shao has reported the acquisition of 78,947 restricted stock units (RSUs) as part of executive compensation, vesting over four years.

Summary

• Wei-Li Shao, President of Omada Health, Inc., acquired 78,947 shares of Common Stock.
• These shares constitute Restricted Stock Units (RSUs), meaning each RSU entitles the reporting person to receive one share of Common Stock upon vesting.
• Vesting occurs quarterly, with 1/16th of the RSUs vesting on each quarterly anniversary starting June 5, 2025 (the "Vesting Commencement Date").
• 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date.
• The acquisition price for these RSUs was $0.

Sentiment

Score: 6

Explanation: The filing reports a standard executive compensation event (RSU grant), which is generally neutral but can be seen as slightly positive for aligning management interests with shareholders. It does not contain any surprising or negative information that would significantly alter sentiment.

Positives

• The grant of 78,947 Restricted Stock Units (RSUs) to President Wei-Li Shao aligns management's long-term interests with those of shareholders.
• RSU grants are a common form of executive compensation, indicating a commitment to retaining key talent and incentivizing long-term performance.

Negatives

• No negative information is presented in this Form 4 filing, as it primarily reports a standard insider compensation transaction.

Risks

• This Form 4 filing primarily reports an insider transaction and does not detail specific company-wide operational or financial risks.

Future Outlook

The vesting schedule for the 78,947 Restricted Stock Units (RSUs) indicates a future commitment of shares to President Wei-Li Shao, with full vesting expected by June 5, 2029, aligning executive incentives with long-term company performance.

Management Comments

• The filing indicates that the transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Industry Context

The grant of Restricted Stock Units (RSUs) to a key executive like the President is a standard practice in the technology and healthcare industries for executive compensation, aiming to incentivize long-term performance and align management interests with shareholder value.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a form of executive compensation is a widely adopted practice across various industries, including technology and digital health, comparable to compensation structures seen in companies like Teladoc Health or other digital health platforms.
• The vesting schedule of four years with quarterly increments is a common industry standard for RSU grants, designed to promote long-term retention and performance among key executives.

Related Party Transactions

• The acquisition of 78,947 Restricted Stock Units (RSUs) by Wei-Li Shao, President of Omada Health, Inc., constitutes an executive compensation transaction between the company and a key insider.

Stakeholder Impact

• Shareholders: The RSU grant aligns the President's financial interests with long-term shareholder value creation, potentially leading to improved performance and retention of key leadership.
• Employees: While not directly impacting all employees, executive compensation practices can influence overall company culture and compensation strategies.

Next Steps

• Vesting of 1/16th of the 78,947 Restricted Stock Units (RSUs) on each quarterly anniversary from June 5, 2025, until fully vested on the fourth anniversary (June 5, 2029).

Key Dates

Keywords

Omada Health, OMDA, Wei-Li Shao, Form 4, SEC filing, Restricted Stock Units, RSU, executive compensation, insider transaction, beneficial ownership